Loading patent…
AssigneeBoard of Regents, The University of Texas System
InventorsSidney Wallace, David Yang, Michael Wallace, Chun Li, Li-Ren Kuang
Estimating the term…
The present invention relates to a highly efficient method of preparing modified microcapsules exhibiting selective targeting. These microcapsules are suitable for encapsulation surface attachment of therapeutic and diagnostic agents. In one aspect of the invention, surface charge of the polymeric material is altered by conjugation of an amino acid ester to the providing improved targeting of encapsulated agents to specific tissue cells. Examples include encapsulation of radiodiagnostic agents in 1 .mu.m capsules to provide improved opacification and encapsulation of cytotoxic agents in 100 .mu.m capsules for chemoembolization procedures. The microcapsules are suitable for attachment of a wide range of targeting agents, including antibodies, steroids and drugs, which may be attached to the microcapsule polymer before or after formation of suitably sized microcapsules. The invention also includes microcapsules surface modified with hydroxyl groups. Various agents such as estrone may be attached to the microcapsules and effectively targeted to selected organs.
A method of selective in vivo delivery to uterus tissue comprising administering to a mammal an effective amount of a pharmaceutically acceptable preparation of poly(benzyl L-glutamate) microspheres covalently attached to estrone.
Poly(benzyl-L-glutamate) microspheres covalently attached to estrone.
Poly(benzyl-L-glutamate) microspheres which are covalently linked to tyramine.
Dependencies are inferred from the claim text.